Immunai
Reuven Mizrahi currently serves as Controller at Immunai, a position held since April 2022, after previously holding the role of Assistant Controller. Prior to this, Reuven Mizrahi gained experience in Assurance Services at EY from October 2019 to April 2022, focusing on the Hi-Tech sector. Reuven Mizrahi earned a degree from Ben-Gurion University of the Negev between 2015 and 2019.
This person is not in any teams
This person is not in any offices
Immunai
2 followers
Immunai is comprehensively mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes.